GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Net Margin %

Genscript Biotech (HKSE:01548) Net Margin % : -0.42% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Genscript Biotech's Net Income for the six months ended in Dec. 2023 was HK$-15 Mil. Genscript Biotech's Revenue for the six months ended in Dec. 2023 was HK$3,500 Mil. Therefore, Genscript Biotech's net margin for the quarter that ended in Dec. 2023 was -0.42%.

The historical rank and industry rank for Genscript Biotech's Net Margin % or its related term are showing as below:

HKSE:01548' s Net Margin % Range Over the Past 10 Years
Min: -73.19   Med: -1.28   Max: 22.81
Current: -11.39


HKSE:01548's Net Margin % is ranked better than
70.67% of 1033 companies
in the Biotechnology industry
Industry Median: -162.58 vs HKSE:01548: -11.39

Genscript Biotech Net Margin % Historical Data

The historical data trend for Genscript Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Net Margin % Chart

Genscript Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.45 -52.44 -73.19 -36.26 -11.37

Genscript Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -102.71 -43.77 -28.90 -23.91 -0.42

Competitive Comparison of Genscript Biotech's Net Margin %

For the Biotechnology subindustry, Genscript Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genscript Biotech's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Net Margin % falls into.



Genscript Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genscript Biotech's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-745.656/6556.554
=-11.37 %

Genscript Biotech's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-14.807/3500.493
=-0.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genscript Biotech  (HKSE:01548) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genscript Biotech Net Margin % Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genscript Biotech (HKSE:01548) Business Description

Traded in Other Exchanges
Address
No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100
GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines